Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine: - whether standard or higher doses of pemetrexed
should be given to patients with ovarian or primary peritoneal cancer that has recurred; -
the safety and side effects of standard and higher doses of pemetrexed given to patients with
ovarian or primary peritoneal cancer that has recurred; - whether standard or higher doses of
pemetrexed can help patients with ovarian or primary peritoneal cancer that has recurred.